04/11/2025 3:28 PM | Bio-Path (Filer)
| Form 1-A Regulation A Offering Statement | |
03/28/2025 7:47 AM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/27/2025 3:42 PM | Bio-Path (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/19/2025 6:15 AM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/07/2025 4:00 PM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/18/2025 6:00 AM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2025 4:26 PM | ARMISTICE CAPITAL, LLC (Filed by) Bio-Path (Subject)
| Form SCHEDULE 13G | |
02/12/2025 9:59 AM | Bio-Path (Filer)
| Form S-1/A | |
01/21/2025 5:10 AM | Bio-Path (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
12/13/2024 4:16 PM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/12/2024 3:15 PM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for BPTH and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Bio-Path and its competitors with MarketBeat's FREE daily newsletter.
|
11/15/2024 6:30 AM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2024 10:15 AM | Bio-Path (Subject) INTRACOASTAL CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
11/06/2024 3:52 PM | Bio-Path (Subject) Hudson Bay Capital Management LP (Filed by)
| Form SC 13G/A | |
10/28/2024 3:32 PM | Bio-Path (Filer)
| Form DEF 14A | |
10/28/2024 3:35 PM | Bio-Path (Filer)
| Form DEFA14A | |
10/28/2024 3:37 PM | Bio-Path (Filer)
| Form ARS | |
10/23/2024 6:00 AM | Bio-Path (Filer)
| Form 424B3 | |
10/22/2024 11:15 PM | Bio-Path (Filer)
| Form EFFECT | |
10/22/2024 2:11 PM | Bio-Path (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/18/2024 4:12 PM | Bio-Path (Filer)
| Form PRE 14A | |
10/17/2024 3:37 PM | Bio-Path (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/10/2024 5:50 PM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2024 4:10 PM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2024 6:30 AM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 3:41 PM | Bio-Path (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024 4:56 PM | Bio-Path (Issuer) Nielsen Peter Henry (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 5:02 PM | Bio-Path (Issuer) MORRIS DOUGLAS P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 5:07 PM | Bio-Path (Issuer) Cleaver Heath (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 5:10 PM | Aubert Paul (Reporting) Bio-Path (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 5:14 PM | Bio-Path (Issuer) Sherwood Aline (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/11/2024 7:38 AM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2024 7:38 AM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/17/2024 7:00 AM | Bio-Path (Filer)
| Form 424B3 | |
06/16/2024 11:15 PM | Bio-Path (Filer)
| Form EFFECT | |
06/14/2024 4:10 PM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2024 6:18 AM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/11/2024 4:30 PM | Bio-Path (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
06/05/2024 4:20 PM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/03/2024 6:10 AM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/15/2024 6:10 AM | Bio-Path (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Trump and Musk fight back (Ad) Is there more to the Musk–Trump relationship than meets the eye?
Jeff Brown thinks so — and he believes it has to do with a top-level initiative to build the ultimate military-grade AI system. He’s calling it the “AI Superweapon,” and he says it could soon become the center of global tech dominance.
At the core of this initiative? A handful of companies tied to America’s most powerful tech platforms — and investors who act before this goes mainstream may have a rare early edge. Click here to see why Jeff believes this is the biggest stock story of the year — and which companie |
05/14/2024 3:10 PM | Bio-Path (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/02/2024 11:15 PM | Bio-Path (Filer)
| Form EFFECT | |
04/24/2024 3:35 PM | Bio-Path (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |